Contract 75N95022C00020
Vesicle Therapeutics Inc · Department Of Health And Human Services · July 2, 2024
Vesicle Therapeutics Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 2, 2024 for $475,000 (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Longmont, CO. It was awarded under a small business set-aside. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $475,000.
Contract details
- PIID
- 75N95022C00020
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Longmont, CO
- First action
- July 2, 2024
Description
NEUROTROPIC GECTOSOMES AS A CNS GENE DELIVERY SYSTEM FOR AD/ADRD THERAPY DEVELOPMENT
Modification timeline
-
July 2, 2024Mod P00003 · Other Administrative Action$475.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95022C00020?
Contract 75N95022C00020 is a federal contract awarded to Vesicle Therapeutics Inc by Department Of Health And Human Services on July 2, 2024 for $475,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75N95022C00020?
Vesicle Therapeutics Inc won contract 75N95022C00020 from Department Of Health And Human Services.
How much is contract 75N95022C00020 worth?
Contract 75N95022C00020 has obligated $0 to date but carries a potential ceiling of $475,000 if fully funded and all options are exercised.